0,889  0,003  GST A substrate
0,866  0,004  Skin irritative effect
0,785  0,005  Eye irritation, high
0,780  0,014  Caspase 9 stimulant
0,769  0,009  Antiarthritic
0,737  0,003  Anesthetic general
0,734  0,011  TNF expression inhibitor
0,688  0,005  Antipsoriatic
0,642  0,011  Mutagenic
0,650  0,020  Antidiabetic
0,650  0,020  Cyclophilin D inhibitor
0,634  0,009  NOS3 expression inhibitor
0,624  0,013  Vasodilator, peripheral
0,600  0,014  Bone diseases treatment
0,586  0,021  Aldehyde oxidase inhibitor
0,587  0,025  Teratogen
0,567  0,018  Immunosuppressant
0,598  0,049  Apoptosis agonist
0,570  0,025  Embryotoxic
0,539  0,003  Porphobilinogen synthase inhibitor
0,521  0,005  Platelet adhesion inhibitor
0,525  0,017  Antiosteoporotic
0,514  0,015  Antidiabetic (type 2)
0,511  0,014  Hypoglycemic
0,496  0,004  GST P1-1 substrate
0,511  0,021  CTGF expression inhibitor
0,495  0,024  Carcinogenic
0,497  0,037  CYP2C9 substrate
0,460  0,003  Succinate dehydrogenase inhibitor
0,458  0,005  GST M1-1 substrate
0,471  0,027  FMO1 substrate
0,449  0,007  Alpha-N-acetylglucosaminidase inhibitor
0,463  0,026  Caspase 3 stimulant
0,442  0,009  FMO3 substrate
0,449  0,020  UGT2B4 substrate
0,452  0,024  Cardiovascular analeptic
0,454  0,026  UGT1A9 substrate
0,456  0,034  CYP2C19 substrate
0,436  0,014  Antiulcerative
0,422  0,003  Alcohol dehydrogenase substrate
0,464  0,048  CYP3A4 substrate
0,440  0,024  Proliferative diseases treatment
0,449  0,036  5 Hydroxytryptamine release stimulant
0,415  0,004  Topoisomerase II alpha inhibitor
0,418  0,011  Anesthetic
0,416  0,011  Melanin inhibitor
0,423  0,021  Radiosensitizer
0,419  0,018  Myocardial infarction treatment
0,415  0,014  Flavin-containing monooxygenase substrate
0,434  0,034  Multiple sclerosis treatment
0,406  0,007  Tyrosine 3 hydroxylase inhibitor
0,488  0,093  Antiinflammatory
0,393  0,002  Fumarate hydratase inhibitor
0,429  0,049  GABA C receptor rho-3 antagonist
0,387  0,009  Muscular dystrophy treatment
0,386  0,007  Antidiabetic (type 1)
0,395  0,017  Abortion inducer
0,382  0,011  Topoisomerase II inhibitor
0,414  0,047  Cholesterol antagonist
0,423  0,058  Antipruritic, allergic
0,406  0,042  Hepatic disorders treatment
0,360  0,004  Triose-phosphate isomerase inhibitor
0,363  0,008  Neurotrophic factor enhancer
0,385  0,031  Calcium channel activator
0,357  0,005  Glutamate dehydrogenase inhibitor
0,381  0,029  Cardiodepressant
0,411  0,061  Transcription factor NF kappa B inhibitor
0,354  0,007  GABA C receptor agonist
0,368  0,020  Antiparkinsonian, rigidity relieving
0,393  0,046  Antihypercholesterolemic
0,368  0,022  Sedative
0,363  0,026  Peroxidase inhibitor
0,409  0,073  5 Hydroxytryptamine release inhibitor
0,338  0,003  Argininosuccinate synthase inhibitor
0,395  0,061  Ulceration
0,358  0,029  DNA synthesis inhibitor
0,349  0,020  Antimutagenic
0,366  0,039  NOS2 expression inhibitor
0,371  0,045  Analeptic
0,369  0,046  CYP1A2 substrate
0,346  0,027  5 Hydroxytryptamine uptake stimulant
0,334  0,015  Lipid peroxidase inhibitor
0,382  0,063  Stroke treatment
0,342  0,025  Septic shock treatment
0,362  0,048  Cardioprotectant
0,356  0,043  Chemoprotective
0,364  0,051  AR expression inhibitor
0,361  0,049  Lipoprotein disorders treatment
0,313  0,009  UDP-glucose 4-epimerase inhibitor
0,377  0,075  CYP2C19 inhibitor
0,325  0,023  Non-steroidal antiinflammatory agent
0,337  0,037  Vasodilator
0,354  0,054  Apoptosis antagonist
0,321  0,022  UGT2B7 substrate
0,310  0,012  Glutathione S-transferase substrate
0,343  0,048  Antioxidant
0,312  0,018  Acaricide
0,338  0,046  Sensitization
0,302  0,011  Topoisomerase I inhibitor
0,298  0,008  Ferrochelatase inhibitor
0,353  0,063  Antithrombotic
0,327  0,038  UGT1A6 substrate
0,324  0,040  Vascular (periferal) disease treatment
0,309  0,027  Gastrin inhibitor
0,346  0,066  Immunostimulant
0,286  0,008  Adenylate kinase inhibitor
0,282  0,005  Carbamoyl phosphate synthetase inhibitor
0,341  0,068  Prostate cancer treatment
0,292  0,021  Hair growth stimulant
0,363  0,094  Histamine release inhibitor
0,289  0,022  Interferon gamma antagonist
0,271  0,003  Hypercalcemia treatment
0,271  0,004  Papain-like protease (SARS coronavirus) inhibitor
0,283  0,020  Antiischemic, cerebral
0,311  0,049  Cytostatic
0,310  0,049  Free radical scavenger
0,283  0,024  UGT1A3 substrate
0,264  0,010  UGT2B10 substrate
0,260  0,007  Phosphofructokinase-1 inhibitor
0,277  0,025  Antiacne
0,314  0,062  Radioprotector
0,300  0,048  Interleukin agonist
0,291  0,042  Nitric oxide antagonist
0,298  0,051  Superoxide dismutase inhibitor
0,255  0,008  Catalase inhibitor
0,276  0,030  Pneumotoxic
0,271  0,027  Lipocortins synthesis antagonist
0,276  0,035  UGT1A4 substrate
0,337  0,098  Atherosclerosis treatment
0,255  0,017  Cholesterol synthesis inhibitor
0,250  0,016  DNA intercalator
0,366  0,133  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,252  0,020  UGT2B9 substrate
0,251  0,024  Monophenol monooxygenase inhibitor
0,246  0,020  Insulin secretagoues
0,246  0,021  Toxic, respiratory center
0,234  0,014  Endometrios treatment
0,230  0,010  Histidine decarboxylase inhibitor
0,282  0,063  Antipyretic
0,231  0,011  Arachidonic acid antagonist
0,233  0,014  Farnesoid X receptor antagonist
0,252  0,034  Antipruritic, non-allergic
0,246  0,028  UGT2B15 substrate
0,230  0,012  MAP kinase kinase 5 inhibitor
0,259  0,042  VCAM1 expression inhibitor
0,246  0,028  Carcinogenic, group 3
0,221  0,004  Antidote, mercury
0,302  0,086  Vasodilator, coronary
0,279  0,065  Amyotrophic lateral sclerosis treatment
0,256  0,045  UGT1A1 substrate
0,234  0,027  Acute respiratory distress syndrome (ARDS) treatment
0,236  0,030  Liver fibrosis treatment
0,262  0,058  Cyclic AMP phosphodiesterase inhibitor
0,262  0,059  Cytotoxic
0,215  0,014  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,204  0,003  Aconitate hydratase inhibitor
0,225  0,025  Uterine stimulant
0,210  0,011  Antineoplastic alkaloid
0,205  0,006  Alcohol oxidase inhibitor
0,229  0,031  CNS active muscle relaxant
0,218  0,022  Antirickettsial
0,227  0,034  Skeletal muscle relaxant
0,243  0,051  UDP-glucuronosyltransferase substrate
0,261  0,070  Antineoplastic (cervical cancer)
0,196  0,006  GST T1-1 substrate
0,214  0,025  SULT1A3 substrate
0,208  0,019  Excitatory amino acid transporter EAAC1 inhibitor
0,194  0,005  Anabolic
0,211  0,028  Antifungal enhancer
0,195  0,017  UGT2B1 substrate
0,208  0,031  Carcinogenic, group 1
0,262  0,086  Spasmolytic
0,182  0,006  Ca2+-transporting ATPase inhibitor
0,196  0,021  Shock treatment
0,181  0,006  UGT2B11 substrate
0,218  0,044  Thrombolytic
0,180  0,011  Electron transport complex I inhibitor
0,207  0,039  Phospholipase A2 inhibitor
0,257  0,090  Insulysin inhibitor
0,187  0,019  Menstruation disorders treatment
0,290  0,124  CYP2C9 inhibitor
0,177  0,011  DOPA decarboxylase inhibitor
0,230  0,064  RNA-directed DNA polymerase inhibitor
0,175  0,011  Keratolytic
0,201  0,037  Skin whitener
0,173  0,010  Glutamate decarboxylase inhibitor
0,180  0,018  GABA C receptor antagonist
0,192  0,031  Neurotrophic factor
0,202  0,042  Antiparkinsonian, tremor relieving
0,256  0,098  Respiratory analeptic
0,179  0,022  Choleretic
0,180  0,024  SULT1A1 substrate
0,216  0,061  Chemopreventive
0,196  0,046  Amylase inhibitor
0,212  0,063  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,167  0,018  Creatine kinase inhibitor
0,158  0,009  Lanosterol 14 alpha demethylase inhibitor
0,177  0,028  Adenylate cyclase stimulant
0,168  0,020  TRPA1 agonist
0,176  0,028  Aminopeptidase B inhibitor
0,175  0,028  Antiviral (Poxvirus)
0,194  0,048  Phospholipase C inhibitor
0,237  0,091  Antineoplastic (bladder cancer)
0,213  0,069  Nitric-oxide synthase stimulant
0,178  0,034  Antihyperlipoproteinemic
0,152  0,009  Acyl-CoA dehydrogenase inhibitor
0,183  0,040  Raynaud's phenomenon treatment
0,173  0,030  Antismoking
0,205  0,062  Hepatoprotectant
0,148  0,007  Glycine receptor agonist
0,248  0,107  CYP2D6 substrate
0,253  0,113  Immunomodulator
0,169  0,029  Microtubule formation inhibitor
0,160  0,020  Antispirochetal
0,165  0,028  Antineoplastic antibiotic
0,179  0,043  Antiseptic
0,187  0,051  Antiviral (Hepatitis C)
0,176  0,040  CF transmembrane conductance regulator agonist
0,147  0,012  Phenylalanine 4-hydroxylase inhibitor
0,173  0,040  Psychosexual dysfunction treatment
0,221  0,088  Neuropeptide Y2 antagonist
0,161  0,029  Vanilloid 1 agonist
0,169  0,038  Aldehyde dehydrogenase inhibitor
0,164  0,033  Pregnane X receptor agonist
0,214  0,083  Antineoplastic (lymphoma)
0,176  0,047  Pancreatic disorders treatment
0,132  0,003  Glucose-6-phosphate isomerase inhibitor
0,146  0,018  Chymotrypsin inhibitor
0,142  0,015  Antihypermotility
0,153  0,026  Antiviral (Influenza B)
0,188  0,063  Muscle relaxant
0,146  0,022  Actinic keratosis treatment
0,153  0,030  Bronchodilator
0,137  0,015  Aminopeptidase I inhibitor
0,171  0,050  GABA C receptor rho-2 antagonist
0,141  0,020  Antiviral (SARS coronavirus)
0,141  0,020  Antiviral (Coronavirus)
0,145  0,024  Androgen antagonist
0,189  0,068  Antiviral (Hepatitis)
0,139  0,020  NADH dehydrogenase inhibitor
0,233  0,114  Antihypoxic
0,162  0,044  Anesthetic local
0,149  0,031  Anticataract
0,144  0,026  Antifungal (Pneumocystis)
0,130  0,012  T cell inhibitor
0,148  0,032  Photosensitizer
0,127  0,010  Antiemphysemic
0,128  0,013  Hyperparathyroidism treatment
0,143  0,028  HIV-1 integrase (Overall Integration) inhibitor
0,197  0,082  Psychostimulant
0,209  0,095  Antihypotensive
0,170  0,057  Hexokinase inhibitor
0,188  0,077  VEGF expression inhibitor
0,147  0,036  Sphingosine 1-phosphate receptor 4 antagonist
0,131  0,021  Antiviral (Rhinovirus)
0,163  0,053  Cell wall synthesis inhibitor
0,146  0,036  Contraceptive female
0,143  0,033  Antihelmintic (Fasciola)
0,137  0,028  GABA C receptor rho-1 antagonist
0,208  0,099  Antiviral (West Nile virus)
0,158  0,049  Sphingosine 1-phosphate receptor 5 antagonist
0,113  0,004  Anesthetic inhalation
0,115  0,008  Antiviral (Parainfluenza)
0,148  0,042  Coagulant
0,130  0,024  ABCA1 expression enhancer
0,161  0,056  Antiprotozoal (Coccidial)
0,111  0,007  Glutamate (mGluR6) antagonist
0,121  0,017  Glycine receptor antagonist
0,192  0,089  Anticonvulsant
0,161  0,059  Genotoxic
0,106  0,004  Cyclophilin A inhibitor
0,105  0,003  Parathyroid hormone antagonist
0,111  0,010  GABA B receptor agonist
0,113  0,013  Anticholelithogenic
0,146  0,046  Sphingosine 1-phosphate receptor 2 antagonist
0,135  0,035  Sulfotransferase substrate
0,196  0,097  Antiviral (HIV)
0,140  0,041  Interleukin 8 antagonist
0,101  0,003  Vitamin D receptor antagonist
0,146  0,049  Proteasome inhibitor
0,113  0,015  Biliverdin reductase inhibitor
0,119  0,022  Contraceptive male
0,137  0,040  Mucolytic
0,262  0,166  Antibacterial
0,159  0,064  Antidote
0,139  0,044  Carcinogenic, group 2B
0,186  0,091  5 Hydroxytryptamine 3E antagonist
0,100  0,007  MDM2 inhibitor
0,118  0,026  Transcription factor NF kappa B stimulant
0,113  0,020  Interferon agonist
0,104  0,012  Antidote, organophosphates
0,134  0,043  Chelator
0,093  0,004  Cytokine production stimulant
0,098  0,010  SULT2A1 substrate
0,220  0,132  Antifungal
0,109  0,021  GABA aminotransferase inhibitor
0,102  0,015  Protease 3C (Human rhinovirus) inhibitor
0,134  0,048  Cystathionine beta-synthase inhibitor
0,176  0,091  CYP2B6 inhibitor
0,095  0,011  Elastase inhibitor
0,094  0,010  Topoisomerase II beta inhibitor
0,111  0,028  Glutathione S-transferase inhibitor
0,187  0,104  Hypolipemic
0,102  0,019  Dysmenorrhea treatment
0,126  0,043  Protease inhibitor
0,097  0,016  Androgen agonist
0,123  0,042  Antineoplastic, alkylator
0,129  0,048  Falcipain 3 inhibitor
0,138  0,058  Antibacterial (Helicobacter pylori)
0,103  0,023  HIV-1 integrase inhibitor
0,248  0,168  Rheumatoid arthritis treatment
0,118  0,039  Prolactin inhibitor
0,132  0,054  Antineoplastic antimetabolite
0,181  0,102  Antiparasitic
0,148  0,069  Antianemic
0,169  0,090  Antihelmintic
0,101  0,023  Estrogen-related receptor beta agonist
0,116  0,038  Alcohol dehydrogenase inhibitor
0,111  0,033  Ornithine decarboxylase inhibitor
0,201  0,124  Antineoplastic (sarcoma)
0,157  0,080  Prostate disorders treatment
0,181  0,106  Antialcoholic
0,103  0,030  Antiviral (Hepatitis A)
0,116  0,046  Gastric antisecretory
0,102  0,032  Granulocyte macrophage colony stimulating factor agonist
0,135  0,066  Antiprotozoal (Trichomonas)
0,106  0,037  Bile acid receptor antagonist
0,121  0,052  Gout treatment
0,109  0,040  Carcinogenic, group 2A
0,157  0,088  Aldehyde oxidase substrate
0,105  0,036  Glutamate release inhibitor
0,148  0,080  Urolithiasis treatment
0,086  0,019  Interferon inducer
0,130  0,063  Cathepsin H inhibitor
0,143  0,076  Thiol protease inhibitor
0,071  0,007  Membrane dipeptidase inhibitor
0,081  0,017  Phosphodiesterase II inhibitor
0,164  0,101  Sepsis treatment
0,080  0,016  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,097  0,034  Na+ K+ transporting ATPase inhibitor
0,139  0,076  Protein kinase stimulant
0,115  0,053  Mediator release inhibitor
0,088  0,027  Antitreponemal
0,065  0,005  ATP citrate lysase inhibitor
0,092  0,032  Narcotic antagonist
0,080  0,021  Ornithine carbamoyltransferase inhibitor
0,098  0,039  NAD(P)H dehydrogenase (quinone) inhibitor
0,079  0,021  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,107  0,049  Electrolyte absorption antagonist
0,128  0,070  Retinoprotector
0,199  0,142  Antiischemic
0,080  0,023  Antimycoplasmal
0,104  0,047  Interleukin 12 antagonist
0,073  0,017  Phosphodiesterase 2A inhibitor
0,071  0,016  Alpha-mannosidase inhibitor
0,218  0,164  Sodium/bile acid cotransporter inhibitor
0,060  0,007  Kainate receptor agonist
0,079  0,026  Purinergic P2X1 antagonist
0,079  0,026  Neuraminidase (influenza) inhibitor
0,062  0,010  Guanylate cyclase inhibitor
0,079  0,027  Exportin-1 inhibitor
0,100  0,048  Calcium antagonist
0,082  0,031  Peroxisome proliferator-activated receptor gamma antagonist
0,151  0,100  ATPase inhibitor
0,088  0,037  NAT1 substrate
0,076  0,025  Andropause treatment
0,064  0,015  Liver X receptor agonist
0,158  0,109  Pyruvate kinase inhibitor
0,106  0,057  Factor V inhibitor
0,141  0,092  Movement disorders treatment
0,109  0,060  Expectorant
0,123  0,074  Cyclooxygenase 3 inhibitor
0,164  0,115  Insulin sensitizer
0,085  0,037  Peroxisome proliferator-activated receptor gamma agonist
0,089  0,041  Antiviral (Dengue virus)
0,100  0,052  Phosphodiesterase 6D inhibitor
0,067  0,020  Dihydroorotate oxidase inhibitor
0,051  0,004  Calcium-independent phospholipase A2 inhibitor
0,066  0,020  Pregnane X receptor antagonist
0,136  0,089  Acetylcholine M1 receptor antagonist
0,106  0,060  Carbonic anhydrase XV inhibitor
0,067  0,022  Leukotriene B4 antagonist
0,125  0,081  Bone formation stimulant
0,053  0,009  Sodium-dependent vitamin C transporter 2 inhibitor
0,055  0,011  p53 inhibitor
0,055  0,013  Squalene synthetase inhibitor
0,053  0,011  3-Hydroxyanthranilate 3,4-dioxygenase inhibitor
0,076  0,035  Leukotriene antagonist
0,081  0,039  Vanilloid 4 agonist
0,052  0,010  Glutamate (mGluR8) agonist
0,132  0,093  Antifungal (Cryptococcus)
0,065  0,027  Lipocortins synthesis agonist
0,111  0,074  Caspase 3 inhibitor
0,054  0,016  Liver X receptor alpha agonist
0,051  0,014  Arginase inhibitor
0,136  0,100  Aldose reductase substrate
0,056  0,020  Mannosidase inhibitor
0,080  0,045  MAP kinase kinase 7 inhibitor
0,049  0,014  Phosphoglycerate kinase inhibitor
0,049  0,015  Nicotinic acid receptor agonist
0,068  0,035  Caspase 9 inhibitor
0,054  0,021  Leukocyte elastase inhibitor
0,097  0,065  Tourette's syndrome treatment
0,046  0,015  Cholesterol absorption inhibitor
0,049  0,018  Dopamine D5 agonist
0,080  0,050  Carbonic anhydrase XIII inhibitor
0,060  0,030  Leukotriene C antagonist
0,036  0,006  Prostaglandin F2 alpha agonist
0,109  0,079  Alkylator
0,172  0,144  Peptidyltransferase inhibitor
0,049  0,021  GABA B receptor antagonist
0,046  0,019  GABA uptake inhibitor
0,055  0,028  Lysophosphatidic acid 3 receptor antagonist
0,066  0,039  Transcription factor RelA inhibitor
0,065  0,038  Neuraminidase inhibitor
0,092  0,065  Antischistosomal
0,148  0,122  Phobic disorders treatment
0,049  0,024  Geranyltranstransferase inhibitor
0,040  0,015  Liver X receptor beta agonist
0,060  0,035  Postcoital contraceptive
0,052  0,027  Aldosterone antagonist
0,052  0,028  Mineralocorticoid receptor antagonist
0,027  0,004  Potassium channel (Inward rectifier) 11 blocker
0,068  0,045  Glutamate (mGluR7) antagonist
0,061  0,038  Sphingosine kinase inhibitor
0,031  0,009  Vanilloid 2 agonist
0,092  0,070  Sphingomyelinase inhibitor
0,045  0,023  Hypogonadism treatment
0,035  0,013  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,026  0,005  Antibiotic Anthracycline-like
0,037  0,016  Peptide deformylase inhibitor
0,085  0,064  Tocolytic
0,142  0,121  Neurotensin receptor agonist
0,032  0,011  Nicotinic acid receptor 2 antagonist
0,027  0,006  Neuraminidase (Influenza B) inhibitor
0,143  0,122  LDLR expression enhancer
0,025  0,004  Vitamin D receptor agonist
0,105  0,085  Antiprotozoal (Babesia)
0,086  0,066  Potassium channel activator
0,064  0,044  Calcium channel P-type blocker
0,081  0,061  Inducible nitric-oxide synthase inhibitor
0,046  0,027  AICAR transformylase inhibitor
0,074  0,055  SULT1A2 substrate
0,051  0,032  Squalene epoxidase inhibitor
0,064  0,045  CDC25B inhibitor
0,023  0,005  Telomerase stimulant
0,030  0,012  Hedgehog signaling activator
0,082  0,064  D-Ala-D-Ala ligase inhibitor
0,035  0,017  Glutamate (mGluR3) agonist
0,049  0,031  Adenosine deaminase inhibitor
0,091  0,073  Carbonic anhydrase III inhibitor
0,071  0,055  Antibiotic
0,031  0,015  Purinergic P2Y15 antagonist
0,168  0,152  Calpain inhibitor
0,162  0,147  Antiviral (Ebola)
0,172  0,157  Huntington's disease treatment
0,049  0,034  HCV NS3/NS4A protease inhibitor
0,108  0,093  Toll-Like receptor 2 antagonist
0,068  0,054  Bulimia treatment
0,050  0,036  Prolyl endopeptidase inhibitor
0,046  0,032  Adenylate cyclase 1 inhibitor
0,030  0,016  Estrogen-related receptor gamma antagonist
0,018  0,005  Calcium-dependent phospholipase A2 inhibitor
0,027  0,014  Lysophosphatidic acid receptor 1 agonist
0,022  0,010  Toll-Like receptor 8 agonist
0,057  0,044  HIV-1 integrase (Strand Transfer) inhibitor
0,025  0,012  GRP78 expression inhibitor
0,039  0,027  Leukotriene C4 antagonist
0,090  0,078  NAT2 substrate
0,101  0,089  Acetylcholine muscarinic antagonist
0,022  0,011  Retinoid X beta receptor antagonist
0,020  0,009  Carbonic anhydrase X inhibitor
0,020  0,009  Carbonic anhydrase VIII inhibitor
0,031  0,020  Prostaglandin agonist
0,081  0,070  Interleukin-1 receptor-associated protein kinase 4 inhibitor
0,035  0,024  Adenosine uptake inhibitor
0,052  0,041  Human rhinovirus A protease inhibitor
0,111  0,102  Antianorexic
0,136  0,127  3C-like protease (Human coronavirus) inhibitor
0,040  0,031  Sphingosine kinase 1 inhibitor
0,050  0,041  Ribonucleoside-diphosphate reductase inhibitor
0,019  0,011  Methylmalonyl-CoA mutase inhibitor
0,058  0,050  NMDA receptor agonist
0,044  0,036  Carbonic anhydrase VII inhibitor
0,015  0,008  Lysophosphatidic acid receptor 3 agonist
0,100  0,092  Aldehyde dehydrogenase substrate
0,036  0,029  Retinoid X receptor antagonist
0,018  0,011  Vesicular glutamate transport inhibitor
0,051  0,045  Sphingosine kinase 2 inhibitor
0,049  0,043  Ribonucleotide reductase inhibitor
0,033  0,026  Retinoid X alpha receptor antagonist
0,052  0,047  Aromatase inhibitor
0,046  0,041  Antiviral (Herpesvirus 3, Human)
0,109  0,104  Antihelmintic (Trematoda)
0,047  0,042  Potassium channel (Inward rectifier) activator
0,056  0,052  Ryanodine receptor antagonist
0,045  0,041  Potassium channel (ATP-sensitive) activator
0,033  0,030  5-Alpha-reductase inhibitor
0,032  0,029  HMG CoA reductase inhibitor
0,005  0,002  Vitamin D-like
0,103  0,101  Contraceptive
0,011  0,010  Glutamate (mGluR6) agonist
0,077  0,076  CC chemokine 5 receptor agonist
0,030  0,029  Retinoid X receptor agonist
0,046  0,045  Factor III inhibitor
0,037  0,036  Thymidine kinase inhibitor
0,061  0,061  Endocannabinoid uptake inhibitor
0,024  0,023  Uridine phosphorylase inhibitor
0,139  0,138  Antieczematic atopic
0,052  0,052  Carbonic anhydrase stimulant

